Current Capital Raising Issues and Strategies for Biotech Companies
You are invited to join Procopio’s Life Sciences Attorneys and the Association of Corporate Counsel-San Diego for a timely presentation that will include discussions on when is the right time to sell your company or license your product(s) to big pharma/biotech.
- David Crean, Ph.D., MBA, Managing Director, Objective Capital
- Dennis Doucette, Partner, Corporate & Securities Practice Group Leader, Procopio
- David Szekeres, Senior Vice President Business Development, General Counsel & Corporate Secretary, Heron Therapeutics, Inc.
5:00 – 5:30 pm | Registration and Networking (beer, wine and light appetizers will be served)
5:30 – 6:30 pm | Roundtable
This event is complimentary to attend but this exclusive roundtable has limited seating. Please register today to secure your spot.
Please note this event is open only to in-house counsel of life sciences companies. Service providers not permitted to attend.
Date & Time
Patrick Ross, Senior Manager of Marketing & Communications
Suzie Jayyusi, Events Planner